About 100 reports

You can easily book an appointment w ith one online.

  • Neurological Disorder
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Koninklijke Philips N.V.
  • Medtronic, Inc.
  • SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)

Spinal cord stimulation involves the implantation of an implanted pulse generator (IPG) in the spinal cord to provide pain relief.

  • Neurological Disorder
  • North America
  • United States
  • Boston Scientific Corporation
  • Medtronic, Inc.

Aug ##, 2018: Alternative patient-controlled pain relief drug could significantly reduce the number of epidurals An alternative patient-controlled pain relief drug could significantly reduce the number of women requiring an epidural during childbirth, a new study

  • Healthcare
  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • INCREASING FOCUS ON RESEARCH

These initiatives enable the efforts to increase awareness among various stakeholders regarding the growing disease burden as well as the technological advances for rapid muscular and pain relief.

  • Neurological Disorder
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sonova Holding AG

Quell is available as over the counter for chronic pain relief.

  • Neurological Disorder
  • Urology Device
  • World
  • Market Size
  • Boston Scientific Corporation

ITS PROPRIETARY PARESTHESIA-FREE HF## THERAPY DELIVERS NEUROMODULATION SOLUTIONS FOR CHRONIC BACK AND LEG PAIN RELIEF.

  • Neurological Disorder
  • Brazil
  • South America
  • B. Braun Melsungen AG
  • Medtronic, Inc.

Global pacemaker electrodes market 2016-2021 ($ millions) Global pacemaker electrodes market: Year-over-year growth 2017-2021 (%) TENS electrodes TENS is used in pain relief therapies.

  • Medical Equipment
  • Neurological Disorder
  • World
  • Forecast
  • Medtronic, Inc.

If the opioid is ineffective in phase ##, the combinations of opioids with either clonidine or bupivacaine are used to give pain relief for individual with neuropathic pain.

  • Neurological Disorder
  • Market Size
  • Flowonix Medical, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • HIGH INCIDENCE RATES OF BRAIN ANEURYSM AND CEREBRAL DISORDERS

Currently, SCS systems are used for pain relief, but in the future, they will be also used to treat angina and asthma.

  • Neurological Disorder
  • World
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Stryker Corporation

TENS IS A THERAPY THAT USES LOW-VOLTAGE ELECTRICAL CURRENT FOR PAIN RELIEF.

  • Neurological Disorder
  • Australasia
  • Australia
  • Oceania
  • Medtronic, Inc.
  • 2. INTRODUCTION

Moreover, VIVENDI provides a reversible treatment for pain relief and as an aid in management of chronic pain through neurostimulation in a specific pain location.

  • Neurological Disorder
  • East Asia
  • North America
  • United States
  • Forecast
  • 7.2.2 BOSTON SCIENTIFIC - NEUROMODULATION PRODUCTS PORTFOLIO
  • 7.3.2 ST. JUDE MEDICAL - NEUROMODULATION PRODUCTS PORTFOLIO

The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. Neuromodulation devices and treatments are life changing....

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.

DIGITAL THERAPEUTICS MARKET FOR CHRONIC PAIN, 2018-2030 ##. ##. ##. ##.

  • Endocrine Disease
  • Neurological Disorder
  • World
  • Market Size
  • VOLUNTIS
  • DATE

Summary The neuromodulation technology utilizes devices that bring about a change in nervous system either by stimulation or modulating brain activity. The treatment delivered by neuromodulation devices brings about life changing transformation in patients who fail to get better by traditional approaches. The opportunities to...

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • INCREASING RESEARCH STUDIES ON ELECTRICAL STIMULATION

THE DEVICE INHIBITS THE PAIN SIGNALS BEFORE THEY REACH THE BRAIN, THUS LEADING TO INDIVIDUALS EXPERIENCING PAIN RELIEF.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.

THE NEED FOR SELF-ADMINISTRATION IS EVIDENT IN EMERGENCY SITUATIONS AND IN CONDITIONS, SUCH AS LIFETHREATENING ALLERGY INDICATIONS, IMMEDIATE PAIN RELIEF FOR WOUNDED MILITARY PERSONNEL DURING WARTIME AND SEVERAL OTHER CONDITIONS.

  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.
  • Sanofi S.A.

IT OFFERS PAIN RELIEF AND ANTI-INFLAMMATORY PROPERTIES.

  • Neurological Disorder
  • Allergan plc
  • Ipsen S.A.
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • 10. Market Growth Drivers

The system is designed to provide improved pain relief to individuals with chronic pain.

  • Neurological Disorder
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Nevro Corporation
  • SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)

Over the years, the global healthcare industry has witnessed a paradigm shift, and is now increasingly focused on minimally invasive therapies that not only treats a wide range of chronic and refractory disorders but also have fewer side effects. The demand for neuromodulation has increased significantly, because of patients’ preference for...

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • CHRONIC SHOULDER PAIN

TODAY, SPR (" STIMULATION FOR PAIN RELIEF" ) THERAPEUTICS OFFERS ITS LEAD PRODUCT, THE SMARTPATCH PNS SYSTEM, FOR CHRONIC POST-STROKE SHOULDER PAIN.

  • Neurological Disorder
  • United States
  • Bioness Inc.
  • Boston Scientific Corporation
  • Cyberonics, Inc.

This gives the company a total of eight topical pain relief products.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Premier Biomedical, Inc.

The company provides pain relief therapies for low back pain and other types of chronic pain.

  • Clinical Trial
  • Health Care Provider
  • Neurological Disorder
  • Therapy
  • Nevro Corporation
  • SMALL MOLECULES TO ANTAGONIZE NMDA RECEPTOR AND CHRNA7 FOR CENTRAL NERVOUS SYSTEM - DRUG PROFILE

The trial is designed to assess the time-to-relief in patients suffering from breakthrough pain.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Grunenthal GmbH

## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## France ## ## ## ## ## ## ## Canada Source: GlobalData' sPharma Intelligence Center Clinic

  • Health Services
  • Neurological Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • Diabetic Peripheral Neuropathy - Product Development Milestones

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Neurological Disorder
  • Pathology
  • Therapy
  • United States
  • ViroMed Co., Ltd.

Pain relief continued to perform well in the quarter, up ##% AER, ##% CER.

  • Neurological Disorder
  • Patient Monitoring
  • Northern Europe
  • United Kingdom
  • AorTech International plc

However, these agents although providing relief, are often poorly tolerated, and require lengthy dose escalation, resulting in sub-optimal efficacy.

  • Mental Health
  • Neurological Disorder
  • United States
  • Product Initiative
  • Allergan plc
  • SMALL MOLECULES TO ANTAGONIZE NMDA RECEPTOR AND CHRNA7 FOR CENTRAL NERVOUS SYSTEM - DRUG PROFILE

Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury.

  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative
  • Grunenthal GmbH
  • Diabetic Peripheral Neuropathy - Product Development Milestones

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Neurological Disorder
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.

However, these agents although providing relief, are often poorly tolerated, and require lengthy dose escalation, resulting in sub-optimal efficacy.

  • Neurological Disorder
  • Neurology
  • Pharmaceutical
  • Therapy
  • Allergan plc